Hence, in a cohort study, we would be able to follow up the patients with prediabetes and observe the incidence of T2D to correlate the incidence with SFRP4 concentrations, and therefore evaluate SFRP4 as a prognostic factor for T2D. This evidence concerns the gene SFRP4 and prediabetes syndrome.